Last reviewed · How we verify
cccDNA assay on liver biopsy — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
cccDNA assay on liver biopsy (cccDNA assay on liver biopsy) — Hospices Civils de Lyon.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| cccDNA assay on liver biopsy TARGET | cccDNA assay on liver biopsy | Hospices Civils de Lyon | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- cccDNA assay on liver biopsy CI watch — RSS
- cccDNA assay on liver biopsy CI watch — Atom
- cccDNA assay on liver biopsy CI watch — JSON
- cccDNA assay on liver biopsy alone — RSS
Cite this brief
Drug Landscape (2026). cccDNA assay on liver biopsy — Competitive Intelligence Brief. https://druglandscape.com/ci/cccdna-assay-on-liver-biopsy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab